Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
Weeks before many people had even heard of the novel coronavirus, Roland Zahn, Ph.D., was already studying the disease—specifically, how it could be stopped.
Alexion’s vision is to continuously raise the bar to deliver on patient expectations with solutions designed for them as people – meaning we want to take the time to understand their social and emotional lives, as well as their medical condition.
As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.
The topic of the meeting: How quickly could the site begin to formulate, fill, package and ship Gilead’s investigational COVID-19 treatment, remdesivir?
At Alkermes, we are closely monitoring and rapidly responding to the impact of COVID-19 on our employees and our communities, and we will continue to update this page periodically. As always, if you have questions for us, please refer to our contact page for information.
April 10, 2020 /3BL Media/ - For more than 170 years, American Express has been committed to backing our colleagues, our customers, our partners and the communities we serve around the world. As we navigate the COVID-19 pandemic, this commitment is more important than ever, and we wanted to share an update on some of the actions we’ve taken during this unprecedented time.
Chairman & CEO Alex Gorsky shares that the company could have the first batches of a Covid-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
By Alex Gorsky, Chairman & CEO,
The Covid-19 pandemic is one of the greatest challenges to our society in living memory.
Yet even as we are heartbroken by the lives lost and the strain on our institutions and communities, countless people have been working tirelessly to offer the world a reason to feel pride, inspiration and hope.
Our newly established testing laboratory in Berlin which supports the fight against the Corona virus is already running: In the lab, our employees – more than 140 have volunteered – are able to conduct up to 1,000 additional SARS-CoV-2 tests per day. This helps to slow down the spread of the virus as fewer infections remain undetected and infection chains can be better reconstructed.